Pfizer painkiller gets longer patent protection
Drugmaker Pfizer Inc. said Tuesday that a new patent on one of its top drugs, anti-inflammatory painkiller Celebrex, extends its U.S. patent protection by 18 months, potentially bringing the company a few billion dollars in additional revenue.
Tags:
Pfizer painkiller gets longer patent protection,
Pfizer Latest News